HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | – | 3,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,071,627 | $739,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 1,391,286 | $960,000 | 0.06% |
| Occidental Asset Management, LLC | 15,834 | $11,000 | 0.01% |
| Waldron Private Wealth LLC | 11,000 | $7,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 80 | $0 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,727 | $4,000 | 0.00% |
| UBS Group AG | 10,200 | $7,000 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |
| NORTHERN TRUST CORP | 17,111 | $11,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 74,832 | $51,000 | 0.00% |